Anjie Xia

912 total citations
26 papers, 404 citations indexed

About

Anjie Xia is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Anjie Xia has authored 26 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in Anjie Xia's work include Cancer therapeutics and mechanisms (4 papers), Catalytic C–H Functionalization Methods (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Anjie Xia is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), Catalytic C–H Functionalization Methods (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Anjie Xia collaborates with scholars based in China and Hong Kong. Anjie Xia's co-authors include Shengyong Yang, Guifeng Lin, Linli Li, Tai‐Ran Kang, Jinliang Yang, Wenting Li, Long He, Quan‐Zhong Liu, Jingming Liu and Xin Mao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Biochemical and Biophysical Research Communications.

In The Last Decade

Anjie Xia

26 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anjie Xia China 9 237 135 49 45 43 26 404
Jamal El Bakali France 12 157 0.7× 183 1.4× 45 0.9× 111 2.5× 14 0.3× 24 405
Verity Sabin United Kingdom 14 172 0.7× 162 1.2× 51 1.0× 51 1.1× 46 1.1× 21 372
Prashi Jain United States 13 180 0.8× 129 1.0× 25 0.5× 22 0.5× 17 0.4× 22 342
Hemantkumar Deokar United States 11 228 1.0× 148 1.1× 24 0.5× 47 1.0× 24 0.6× 20 380
Ming Guo China 8 353 1.5× 132 1.0× 17 0.3× 20 0.4× 44 1.0× 14 540
Mickaël Jean France 12 179 0.8× 231 1.7× 9 0.2× 53 1.2× 32 0.7× 27 426
Matthew W. Martin United States 12 204 0.9× 107 0.8× 15 0.3× 36 0.8× 29 0.7× 19 338
Jacky B. Buckton United Kingdom 8 126 0.5× 74 0.5× 20 0.4× 23 0.5× 27 0.6× 10 338
Snahel Patel United States 9 187 0.8× 86 0.6× 31 0.6× 30 0.7× 14 0.3× 10 325
Emmanuel O. Johnson United States 6 154 0.6× 250 1.9× 16 0.3× 26 0.6× 34 0.8× 7 481

Countries citing papers authored by Anjie Xia

Since Specialization
Citations

This map shows the geographic impact of Anjie Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anjie Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anjie Xia more than expected).

Fields of papers citing papers by Anjie Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anjie Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anjie Xia. The network helps show where Anjie Xia may publish in the future.

Co-authorship network of co-authors of Anjie Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Anjie Xia. A scholar is included among the top collaborators of Anjie Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anjie Xia. Anjie Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Chao, Guifeng Lin, Xin Yang, et al.. (2024). Structure-based identification of a G protein–biased allosteric modulator of cannabinoid receptor CB1. Proceedings of the National Academy of Sciences. 121(24). e2321532121–e2321532121. 13 indexed citations
2.
Lin, Guifeng, Anjie Xia, Jingxin Qiao, et al.. (2024). Identification of a new class of activators of the Hippo pathway with antitumor activity in vitro and in vivo. Biochemical Pharmacology. 224. 116217–116217. 2 indexed citations
3.
Huang, Chong, Jingxin Qiao, Yueyue Li, et al.. (2023). Discovery of 3-phenyl-1,2,4-oxadiazole derivatives as a new class of SARS-CoV-2 main protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 86. 129238–129238. 4 indexed citations
4.
Zhang, Yun, Jiao Yan, Anjie Xia, et al.. (2023). Discovery of a novel pyroptosis inhibitor acting though modulating glutathionylation to suppress NLRP3-related signal pathway. International Immunopharmacology. 127. 111314–111314. 5 indexed citations
5.
Zhou, Pei, Jinlong Zhao, Qian Hu, et al.. (2023). Discovery of (S)-3-(4-(benzyloxy)phenyl)-2-(2-phenoxyacetamido)propanoic acid derivatives as a new class of GPR34 antagonists. Bioorganic & Medicinal Chemistry Letters. 97. 129548–129548. 2 indexed citations
6.
Zhang, Guo, Chenyu Tian, Anjie Xia, et al.. (2023). Discovery of 5-((1H-indazol-3-yl) methylene)-2-thioxoimidazolidin-4-one derivatives as a new class of AHR agonists with anti-psoriasis activity in a mouse model. Bioorganic & Medicinal Chemistry Letters. 92. 129383–129383. 5 indexed citations
7.
Wang, Falu, Rui Zeng, Jingxin Qiao, et al.. (2023). Discovery of benzodiazepine derivatives as a new class of covalent inhibitors of SARS-CoV–2 main protease. Bioorganic & Medicinal Chemistry Letters. 92. 129407–129407. 6 indexed citations
8.
Huang, Chong, Rui Zeng, Jingxin Qiao, et al.. (2023). Discovery and structure-activity relationship studies of novel α-ketoamide derivatives targeting the SARS-CoV-2 main protease. European Journal of Medicinal Chemistry. 259. 115657–115657. 7 indexed citations
9.
Yang, Xin, Xuehui Wang, Zheng Xu, et al.. (2022). Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1. Nature Chemical Biology. 18(8). 831–840. 67 indexed citations
10.
Yan, Jiao, Bo Mu, Yun Zhang, et al.. (2022). Discovery of a novel and potent inhibitor with differential species-specific effects against NLRP3 and AIM2 inflammasome-dependent pyroptosis. European Journal of Medicinal Chemistry. 232. 114194–114194. 43 indexed citations
11.
Yang, Chao, Anjie Xia, Mingxing Hu, et al.. (2022). Discovery of highly potent and selective 7-ethyl-10-hydroxycamptothecin-glucose conjugates as potential anti-colorectal cancer agents. Frontiers in Pharmacology. 13. 1014854–1014854. 7 indexed citations
12.
You, Jing, Wei Yang, Anjie Xia, et al.. (2022). Discovery of 2-vinyl-10H-phenothiazine derivatives as a class of ferroptosis inhibitors with minimal human Ether-a-go-go related gene (hERG) activity for the treatment of DOX-induced cardiomyopathy. Bioorganic & Medicinal Chemistry Letters. 74. 128911–128911. 15 indexed citations
13.
Chen, Pei, Yan Jiao, Guifeng Lin, et al.. (2022). Discovery of 6,7-dihydro-5H-pyrrolo[3,4-d] pyrimidine derivatives as a new class of ATR inhibitors. Bioorganic & Medicinal Chemistry Letters. 63. 128651–128651. 8 indexed citations
14.
Yang, Xin, Guifeng Lin, Anjie Xia, et al.. (2022). Discovery of Small Molecule Agonist of Gonadotropin-Releasing Hormone Receptor (GnRH1R). Journal of Chemical Information and Modeling. 62(20). 5009–5022. 7 indexed citations
15.
Fang, Zhen, Bo Mu, Yang Liu, et al.. (2022). Discovery of a potent, selective and cell active inhibitor of m6A demethylase ALKBH5. European Journal of Medicinal Chemistry. 238. 114446–114446. 50 indexed citations
16.
Zhang, Yun, Anjie Xia, Shiyu Zhang, et al.. (2021). Discovery of 3,6-disubstutited-imidazo[1,2-a]pyridine derivatives as a new class of CLK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 41. 127881–127881. 5 indexed citations
17.
Li, Wenting, Minhao Huang, Anjie Xia, et al.. (2021). C3 ester side chain plays a pivotal role in the antitumor activity of Maytansinoids. Biochemical and Biophysical Research Communications. 566. 197–203. 8 indexed citations
18.
Mao, Xin, Liang Xiong, Anjie Xia, et al.. (2021). Structure‐Guided Discovery of a Potent and Selective Cell‐Active Inhibitor of SETDB1 Tudor Domain. Angewandte Chemie. 133(16). 8842–8847. 1 indexed citations
19.
Qiao, Jingxin, Guifeng Lin, Anjie Xia, et al.. (2019). Discovery of 1,8-disubstituted-[1,2,3]triazolo[4,5-c]quinoline derivatives as a new class of Hippo signaling pathway inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(18). 2595–2603. 8 indexed citations
20.
Xia, Anjie, Xin Mao, Xiaoai Wu, et al.. (2019). Metal-Free Aerobic Oxidative Selective C–C Bond Cleavage in Heteroaryl-Containing Primary and Secondary Alcohols. Organic Letters. 21(9). 3028–3033. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamal El Bakali Breakdown of academic impact, for papers by Verity Sabin Breakdown of academic impact, for papers by Prashi Jain Breakdown of academic impact, for papers by Hemantkumar Deokar Breakdown of academic impact, for papers by Ming Guo Breakdown of academic impact, for papers by Mickaël Jean Breakdown of academic impact, for papers by Matthew W. Martin Breakdown of academic impact, for papers by Jacky B. Buckton Breakdown of academic impact, for papers by Snahel Patel Breakdown of academic impact, for papers by Emmanuel O. Johnson
Rankless by CCL
2026